Spectral MD wins $1.1m contract with US Department of Defense

Predictive analytics company Spectral MD has been awarded $1.1m to advance its artificial intelligence wound healing assessment technology for use in a "far-forward military environment" and improve portability.

Spectral said on Thursday that it had been awarded the two-year sequential phase II small business technology transfer contract from the Defense Health Agency within the US Department of Defense and will advance a new, multispectral imaging sensor intended to enable the development of a fully handheld version of its existing AI and MSI technology, DeepView.

The AIM-listed group stated that developments achieved under the contract will also support improvements in portability and ease of use for the assessment of civilian burn and chronic wound applications, such as diabetic foot ulcers.

Chief executive Wensheng Fan said: "Working with the US military to enable DeepView's burn assessment capability in field hospitals is crucial to reaching wounded soldiers closer to the battlefield. DeepView is supported by multiple US federal agencies for both military and civilian uses.

"In addition, this development will also directly benefit the DFU indication by facilitating an expansion into remote care settings including the potential for home health."

As of 1025 BST, Spectral MD shares were down 2.42% at 60.50p.